Direct measurement of lipid hydroperoxides in iron-dependent spinal neuronal injury

Journal of Neurochemistry

Volumn 66, Issue 1, 1996, Pages 355-361

  Zhang, Jue Rong ^a   Scherch, Heidi M ^a   Hall, Edward D ^a  

^a PFIZER INC   (United States)

Author keywords

HPLC chemiluminescence; Iron; Lipid peroxidation; Neuron; Phosphatidylcholine hydroperoxide; Phosphatidylethanolamine hydroperoxide

Indexed keywords

HYDROPEROXIDE DERIVATIVE; IRON; LIPID PEROXIDE; PHOSPHATIDYLETHANOLAMINE;

ANIMAL CELL; ARTICLE; CELL VIABILITY; FETUS; LIPID PEROXIDATION; MOUSE; NERVE DEGENERATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SPINAL CORD INJURY; SPINAL NERVE; SPINE INJURY;

ANIMALIA;

EID: 0030071251     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.66010355.x     Document Type: Article

References (25)

1. Arendash G. W., Olanow C. W., and Sengstock G. J. (1993) Intranigral iron infusion in rats: a progressive model for excess nigral iron levels in Parkinson's disease, in Iron in Central Nervous System Disorders (Riederer P. and Youdim M. B. H., eds), pp. 87-101. Springer-Verlag, Wien/New York.
2. Benkovic S. A. and Connor J. R. (1993) Ferritin, transferrin, and iron in selected regions of the adult and aged rat brain. J. Comp. Neurol. 338, 97-113.
3. Braughler J. M., Duncan L. A., and Goodman T. (1985) Calcium enhances in vitro free radical-induced damage to brain synaptosomes, mitochondria, and cultured spinal cord neurons. J. Neurochem. 45, 1288-1293.
4. Buxser S. and Bonventre P. F. (1981) Staphylococcal enterotoxins fail to disrupt membrane integrity or synthetic function of Henle 407 intestinal cells. Infect. Immun. 31, 929-934.
5. Connor J. R. (1993) Cellular and regional maintenance of iron homeostasis in the brain: normal and diseased states, in Iron in Central Nervous System Disorders (Riederer P. and Youdim M. B. H., eds), pp. 1-18. Springer-Verlag, Wien/New York.
6. Floyd R. A. and Carney J. M. (1991) Age influence on oxidative events during brain ischemia/reperfusion. Arch. Gerontol. Geriatr. 12, 155-177.
7. Gerlach M., Ben-Shachar D., Riederer P., and Youdim M. B. H. (1994) Altered brain metabolism of iron as a cause of neurodegenerative diseases? J. Neurochem. 63, 793-807.
8. Hall E. D. and Braughler J. M. (1993) Free radicals in CNS injury, in Molecular and Cellular Approaches to the Treatment of Neurological Disease (Waxman S. G., ed), pp. 81-105. Raven Press, New York.
9. Hall E. D., Braughler J. M., Yonkers P. A., Smith S. L., Linseman K. L., Means E. D., Scherch H. M., Von Voigtlander P. F., Lahti R. A., and Jacobsen E. J. (1991) U-78517F: a potent inhibitor of lipid peroxidation with activity in experimental brain injury and ischemia. J. Pharmacol. Exp. Ther. 258, 688-694.
10. Hall E. D., McCall J. M., and Means E. D. (1994) Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous system trauma, ischemia, and subarachnoid hemorrhage. Adv. Pharmacol. 28, 221-268.
11. Halliwell B. (1992) Reactive oxygen species and the central nervous system. J. Neurochem. 59, 1609-1623.
12. Jellinger K. and Kienzl E. (1993) Iron deposits in brain disorders, in Iron in Central Nervous System Disorders (Riederer P. and Youdim M. B. H., eds), pp. 19-36. Springer-Verlag, Wien/ New York.
13. 2+ in the presence of xylenol orange. Comparison with the TBA assay and an iodometric method. Lipids 26, 853-856.
14. Lutzke B. S. and Braughler J. M. (1990) An improved method for the identification and quantitation of biological lipids by HPLC using laser light-scattering detection. J. Lipid Res. 31, 2127-2130.
15. Miyazawa T., Yasuda K., and Fujimoto K. (1987) Chemiluminescence-high performance liquid chromatography of phosphatidylcholine hydroperoxide. Anal. Lett. 20, 915-925.
16. Miyazawa T., Suzuki T., Fujimoto K., and Kaneda T. (1990) Phospholipid hydroperoxide accumulation in liver of rats intoxicated with carbon tetrachloride and its inhibition by dietary α-tocopherol. J. Biochem. (Tokyo) 107, 689-693.
17. Pryor W. A. and Godber S. S. (1991) Noninvasive measures of oxidative stress status in humans. Free Radic. Biol. Med. 10, 177-184.
18. Sevanian A. (1988) Phospholipase and lipid peroxidation. CRC Reviews: Cellular Antioxidant Defense Mechanisms 2, 77-95.
19. 2: protection of membranes from lipid peroxidation damage. Trends Biochem. Sci. 12, 31-34.
20. White D. A. (1973) The phospholipid composition of mammalian tissues, in Form and Function of Phospholipids (Ansell G. B., Hawthorne J. N., and Dawson R. M. C., eds), pp. 441-482. Elsevier, Amsterdam.
21. Yamamoto Y., Brodsky M. H., Baker J. C., and Ames B. N. (1987) Detection and characterization of lipid hydroperoxides at picomole levels by high-performance liquid chromatography. Anal. Biochem. 160, 7-13.
22. Youdim M. B. H., Ben-Shachar D., and Riederer P. (1993) The possible role of iron in the etiopathology of Parkinson's disease. Mov. Disord. 8, 1-12.
23. Zhang J.-R. and Sevanian A. (1993) The genotoxic effects of arachidonic acid in V79 cells are mediated by peroxidation products. Toxicol. Appl. Pharmacol. 121, 193-202.
24. Zhang J.-R., Andrus P. K., and Hall E. D. (1994) Age-related phospholipid hydroperoxide levels in gerbil brain measured by HPLC-chemiluminescence and their relation to hydroxyl radical stress. Brain Res. 639, 275-282.
25. Zhang J.-R., Cazers A. R., Lutzke B. S., and Hall E. D. (1995) HPLC-chemiluminescence and thermospray LC/MS study of hydroperoxides generated from phosphatidylcholine. Free Radic. Biol. Med. 18, 1-10.